Wafaa El-Sadr Selected Research

Anti-HIV Agents (AIDS Drugs)

10/2019	Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
8/2019	Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study.
1/2019	Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.
10/2012	Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
10/2010	Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
2/2010	Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.
1/2010	High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.
3/2009	Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.
2/2009	Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wafaa El-Sadr Research Topics

Disease

12	Myocardial Infarction 01/2018 - 04/2007
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2003
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 10/2005
5	Tuberculosis (Tuberculoses) 06/2014 - 08/2004
5	HIV Infections (HIV Infection) 02/2014 - 05/2003
4	Stroke (Strokes) 08/2019 - 01/2013
4	Diabetes Mellitus 10/2012 - 05/2003
3	Infections 01/2021 - 08/2006
3	Hypertension (High Blood Pressure) 01/2014 - 05/2003
3	Lipodystrophy 10/2012 - 05/2003
3	Coronary Disease (Coronary Heart Disease) 02/2009 - 05/2003
2	Neoplasms (Cancer) 01/2021 - 01/2019
2	Insulin Resistance 10/2012 - 06/2008
2	Dyslipidemias (Dyslipidemia) 10/2012 - 04/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010 - 03/2009
2	Malaria 12/2009 - 01/2009
1	COVID-19 01/2021
1	Viremia 01/2021
1	Chronic Renal Insufficiency 10/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Pulmonary Tuberculosis 06/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2013
1	Cryptococcal Meningitis 07/2010
1	Disease Progression 11/2009

Drug/Important Bio-Agent (IBA)

9	Anti-HIV Agents (AIDS Drugs)IBA 10/2019 - 02/2009
6	Pharmaceutical PreparationsIBA 01/2018 - 05/2003
5	LipidsIBA 01/2014 - 05/2003
3	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2003
3	Protease Inhibitors (Protease Inhibitor)IBA 10/2019 - 04/2007
3	abacavir (Ziagen)FDA Link 01/2018 - 04/2008
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 04/2007
3	AcidsIBA 06/2014 - 08/2006
3	Triglycerides (Triacylglycerol)IBA 01/2014 - 03/2009
3	CholesterolIBA 01/2014 - 05/2003
2	NucleosidesIBA 01/2018 - 04/2008
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 01/2013
2	Ritonavir (Norvir)FDA Link 01/2018 - 01/2013
2	Antihypertensive Agents (Antihypertensives)IBA 01/2014 - 01/2010
2	HDL CholesterolIBA 07/2011 - 03/2009
2	Didanosine (Videx)FDA LinkGeneric 02/2010 - 04/2008
2	Lamivudine (Epivir)FDA Link 02/2010 - 04/2008
2	insulin receptor-related receptor (IRR)IBA 12/2009 - 01/2009
1	AntigensIBA 01/2021
1	pitavastatin (itavastatin)FDA Link 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Serum AlbuminIBA 01/2018
1	ritonavir drug combination atazanavirIBA 01/2018
1	BilirubinIBA 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2014
1	Alanine Transaminase (SGPT)IBA 08/2013
1	Biological ProductsIBA 07/2013
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 07/2010
1	liposomal amphotericin B FDA Link 07/2010
1	deoxycholate drug combination amphotericin BIBA 07/2010
1	Amphotericin B (Amphotericin)FDA LinkGeneric 07/2010
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2010
1	efavirenz (Sustiva)FDA Link 02/2010
1	Oral ContraceptivesIBA 11/2009
1	ThymidineIBA 06/2008
1	Zidovudine (Retrovir)FDA LinkGeneric 04/2008
1	Stavudine (Zerit)FDA LinkGeneric 04/2008
1	Tuberculin (PPD)IBA 08/2006
1	Interferon-gamma (Interferon, gamma)IBA 08/2006
1	Rifabutin (Ansamycin)FDA Link 02/2006
1	RifamycinsIBA 02/2006
1	Isoniazid (Ftivazide)FDA LinkGeneric 02/2006
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2006
1	Pyrazinamide FDA LinkGeneric 02/2006
1	Ethambutol (Myambutol)FDA LinkGeneric 02/2006

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2003
5	Highly Active Antiretroviral Therapy (HAART) 10/2012 - 08/2004
4	Art Therapy 01/2021 - 02/2014
1	Carotid Endarterectomy 01/2018
1	Transplantation 01/2014
1	Endarterectomy (Thromboendarterectomy) 01/2014
1	Ambulatory Care (Outpatient Care) 01/2013
1	Injections 11/2009
1	Hormonal Contraception 11/2009